Arkolith/Insider Trading/APLT/Form 4

Shendelman Shoshana

President and CEO, Director, 10% OwnerApplied Therapeutics Inc. (APLT) · full profile →Form 4 · filed Dec 1, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2023Sell(S)4K$1.97$8K2.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057117) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML